
Evolent Bets on AI-Led Operations as It Raises 2026 Revenue Outlook
Evolent raised its 2026 revenue guidance after reporting 47% revenue growth in Q2, with executives pointing to an AI-led operating model and new oncology partnerships.
PharmaCompany
Evolent Health raised its 2026 revenue guidance following a 47% revenue growth in Q2. The company is focusing on an AI-led operating model and has established new partnerships in oncology.
+0 in the last 30 days
Latest: Aug 7, 2026
Latest tracker entry
47% revenue growth
operational efficiency




MachineCon USA · from AIM Media House
An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.



